Screener
Immunovant, Inc. IMVT Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Immunovant, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The source filing: Immunovant, Inc.’s 10-K, filed May 20, 2026.
- Filed
- May 20, 2026, 7:28 AM EDT
- Fiscal year
- FY2026
- Accession
- 0001764013-26-000064
| Line item | March 31, 2026 | March 31, 2025 |
|---|---|---|
| Series A preferred stock, par value $0.0001 per share, 10,000 shares authorized, issued and outstanding at March 31, 2026 and March 31, 2025 | — | — |
| Preferred stock, par value $0.0001 per share, 10,000,000 shares authorized, no shares issued and outstanding at March 31, 2026 and March 31, 2025 | — | — |
| Common stock, par value $0.0001 per share, 500,000,000 shares authorized, 203,940,353 shares issued and outstanding at March 31, 2026 and 500,000,000 shares authorized, 170,111,593 shares issued and outstanding at March 31, 2025 | 20 | 16 |
| Additional paid-in capital | 2,596,971 | 1,945,495 |
| Accumulated other comprehensive income | 730 | 1,459 |
| Accumulated deficit | (1,745,129) | (1,239,523) |
| Total stockholders’ equity | 852,592 | 707,447 |
| Total liabilities and stockholders’ equity | $957,014 | $776,222 |
Item 8. Financial Statements and Supplementary Data
FAQ
- What is Immunovant, Inc.'s retained earnings?
- Immunovant, Inc. (IMVT) reported retained earnings of -$1.75B in Q1 2026.
- How has Immunovant, Inc.'s retained earnings changed year-over-year?
- Immunovant, Inc.'s retained earnings decreased by 40.8% year-over-year, from -$1.24B to -$1.75B.
- What is the long-term trend for Immunovant, Inc.'s retained earnings?
- Over 5 years (2021 to 2026), Immunovant, Inc.'s retained earnings has grown at a 54.4% compound annual growth rate (CAGR), from -$198.66M to -$1.75B.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.
Ask your AI about Immunovant, Inc.'s retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude